Holocene Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,917,196
Closed -$279M 717
2023
Q3
$279M Buy
+3,917,196
New +$293M 1.22% 12
2023
Q1
Sell
-1,269,333
Closed -$100M 734
2022
Q4
$100M Sell
1,269,333
-561,418
-31% -$42.1M 0.61% 57
2022
Q3
$129M Buy
1,830,751
+1,708,478
+1,397% +$134M 0.82% 30
2022
Q2
$9.8M Sell
122,273
-77,727
-39% -$6.08M 0.06% 216
2022
Q1
$15.2M Buy
200,000
+95,531
+91% +$7.57M 0.08% 202
2021
Q4
$8.91M Sell
104,469
-2,074,584
-95% -$162M 0.05% 228
2021
Q3
$165M Buy
2,179,053
+1,703,770
+358% +$135M 0.9% 22
2021
Q2
$38.7M Buy
+475,283
New +$38.9M 0.22% 144
2020
Q2
Sell
-71,292
Closed -$4.73M 632
2020
Q1
$4.73M Sell
71,292
-1,436,255
-95% -$101M 0.05% 180
2019
Q4
$104M Buy
1,507,547
+9,203
+0.6% +$627K 0.93% 31
2019
Q3
$110M Buy
1,498,344
+473,026
+46% +$34.3M 1.13% 24
2019
Q2
$73.5M Sell
1,025,318
-165,922
-14% -$11.8M 0.94% 33
2019
Q1
$81.6M Buy
1,191,240
+291,114
+32% +$18.8M 1.25% 27
2018
Q4
$53.6M Buy
+900,126
New +$56.3M 0.86% 42
2018
Q2
Sell
-8,364
Closed -$600K 593
2018
Q1
$600K Buy
+8,364
New +$602K 0.01% 86

Other funds holding CL

Holocene Advisors's CL Position: Q4 2023 in Review

Holocene Advisors sold out of Colgate-Palmolive (CL) in Q4 2023, closing a stake of 3,917,196 shares — an estimated $279M sold.

Holocene Advisors first reported a position in CL in Q1 2018 and held it in 15 quarters. The position peaked at $279M in Q3 2023. 1,740 funds tracked by Wall St. Rank hold CL as of Q4 2023.

  • Holocene Advisors reported no remaining Colgate-Palmolive position as of Q4 2023 after selling out during the quarter.
  • Holocene Advisors sold 3,917,196 Colgate-Palmolive shares in Q4 2023, an estimated $279M.
  • Holocene Advisors first reported a position in Colgate-Palmolive in Q1 2018 and held it in 15 quarters.
  • Holocene Advisors's Colgate-Palmolive position peaked at $279M in Q3 2023.
  • 1,740 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on Holocene Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.